TB Partnership looking for Trial Sites - The Critical Path to TB Drug Regimens (CPTR)

The Critical Path to TB Drug Regimens (CPTR) Initiative is looking for new trial sites. We are inviting potential sites to get in touch and we welcome any feedback or ideas on how we could reach sites that might wish to be involved in this programme. We have placed an article in the resources area of Global Health Trials. In this article we list the information that we seek from possible collaborative sites.

The aim aim of CPTR is to accelerate the development of new, safe, and highly effective tuberculosis (TB) treatment regimens with shorter therapy durations. The group is a broad collaboration of pharmaceutical companies; government, regulatory, and multilateral agencies; academia; civil society; advocates; and non-government organizations, and the website can be found at: http://www.c-path.org/CPTR.cfm.

The partnership is planning TB drug Phase I/II trials and is seeking high quality research sites in high burden countries for TB especially Uganda, South Korea, South Africa, Peru, India, China. Please share your thoughts on how we can best use this professional community to seek collaborators for these trials. If you are interested in registering your interest please get in touch by sending an email to info@globalhealthtrials.org and provide as much detail as possible on the following questions

1. Details of any previous experience of TB clinical research
2. Details of any previous clinical trial experience
3. Brief indication of local TB burden
4. Local clinical trial regulatory requirements
5. Contact info for the Ethics Committee(s) and any national clinical trial approval committees (if possible) and meeting frequency (if known)
6. Details of study drug import requirements (if known)